Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2023

Dec 30, 2023

32044_dirs_2023-12-29_06493f48-db12-4e39-903a-2cc9b218b2a7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2023-12-28

Reporting Person: KINDLER JEFFREY B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-28 Common Stock S 96686 $1.41 Disposed 238275 Direct

Footnotes

F1: On December 28, 2023, Jeffrey Kindler, a Director of the Issuer, entered into a Stock Purchase Agreement with Parkview 2020 Limited Partnership ("Parkview 2020"), an affiliate of Randal J. Kirk, also a Director of the Issuer, pursuant to which Parkview 2020 purchased from Mr. Kindler 96,686 shares of common stock of the Issuer at a price per share of $1.41, which purchase price was determined based upon the closing price of the Issuer's common stock on December 28, 2023.